CD4 and cutaneous mastocytosis: Since 2016, the Nigerian National guidelines for HIV prevention, treatment, and care recommend CrAg screening in ART naïve adults with CD4< 200 cells/mm3 followed by pre-emptive antifungal therapy to prevent CM in patients with antigenemia in whom concurrent CM is ruled out [12].